![]()
|
|
||||||||
J. Biol. Chem., Vol. 277, Issue 40, 36905-36908, October 4, 2002
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
-Keto Acid Dehydrogenase Kinase*
From the Departments of Biochemistry and Internal Medicine, University of Texas Southwestern Medical Center, Dallas, Texas 75390
Received for publication, July 30, 2002
| |
ABSTRACT |
|---|
|
|
|---|
The branched-chain The mammalian mitochondrial branched-chain The structures of rat BCK in the apo-, ADP-bound, and ATP To approach this hypothesis, we have focused on the putative
interaction of BCK with the N-terminal lipoic acid-bearing domain (LBD)
of E2b, by analogy to the binding of the L2 domain of E2p to PDK (12).
However, these studies have been hampered by the fact the lipoylated
LBD (lip-LBD) alone (residues 1-84) cannot bind to BCK. Here we report
that the previously overlooked C-terminal hinge region of LBD is
essential for the interaction of lip-LBD with BCK. Constructs
containing lip-LBD and various lengths of the C-terminal hinge region
are able to bind to BCK to different degrees, as measured by a newly
developed solubility-based assay and by isothermal titration
calorimetry (ITC). The absence of relevant C-terminal hinge sequences
may explain the previously observed weak binding of some PDK isoforms
to the L2 domain of the PDC (13). More significantly, the inclusion of
the C-terminal hinge region will facilitate investigations into the
mechanism by which mitochondrial protein kinases, i.e. BCK
and PDK isoforms, are regulated through interactions with their
respective E2 cores of Construction of Expression Plasmids for E2b Domains--
The
di-domain (DD), which spanned residues 1-167 of human E2b, contained
(5' Expression and Lipoylation of DD and LBD
Constructs--
C-terminally His6-tagged E2 domain
constructs were transformed into BL-21 cells, and the expression at
30 °C was induced by 0.75 mM
isopropyl- Solubility-based Binding Assays for His6-tagged
BCK--
N-terminally His6-tagged BCK (40 µM, monomers) in 400 mM arginine was combined
with lipoylated or unlipoylated DD or LBD constructs (70 µM). Each of the mixtures was dialyzed at 4 °C for
16 h against 50 mM Hepes buffer, pH 7.5, containing 50 mM KCl, 5 mM dithiothreitol, 1 mM
MgCl2, and 5% glycerol. The dialyzed mixtures were
clarified by centrifugation, and aliquots were analyzed by SDS-PAGE and Coomassie Blue staining.
Binding Studies of Maltose-binding Protein (MBP)-BCK with
Lipoylated E2 Domain Constructs by Isothermal Titration
Calorimetry--
MBP-BCK and lip-DD or lip-LBD constructs were
dialyzed exhaustively with three changes against the same reservoir of
50 mM potassium phosphate buffer, pH 7.5, 50 mM
KCl, 20 mM Other Methods--
The construction and expression of
His6-tagged BCK and MBP-BCK by co-transformation with the
pGroESL plasmid overproducing chaperonins GroEL and GroES were
described previously (7, 11).
Interactions of His6-tagged BCK with Lipoylated
Di-domain--
A DD (residues 1-167) construct comprising the LBD,
a hinge region, and the SBD was expressed and lipoylated in
vitro and designated as lip-DD. The N-terminally
His6-tagged BCK is soluble to the extent of 2-3 mg/ml only
in the presence of 300 mM arginine (7). However, the
requirement of high arginine concentration for solubility was
circumvented when N-terminally His6-tagged BCK was allowed
to bind to lip-DD. Based on this finding, a solubility-based binding
assay was developed. Lip-DD was combined with the N-terminally His6-tagged BCK in the presence of 400 mM
arginine. The mixture was dialyzed to remove arginine because it
interferes with the binding of lip-DD to BCK (data not shown). The
solubility of His6-tagged BCK was indicated by its presence
in the supernatant following dialysis and centrifugation. As shown in
Fig. 1, in the presence of lip-DD,
His6-tagged BCK remains in the supernatant after the removal of arginine (lane 2). The monomeric subunit
stoichiometry of His6-tagged BCK to lip-DD is 1:2. The
presence of excess lip-DD is necessary to prevent the precipitation of
His6-tagged BCK during dialysis. In contrast, incubation of
His6-tagged BCK with unlipoylated apo-DD does not render
the former soluble in the absence of arginine (lane 3).
These data confirm the finding that the covalently attached lipoic acid
is essential for the binding of holo-E2p to PDK (16). In contrast,
incubation with LBD (residues 1-84) alone, whether lipoylated
(lane 4) or unlipoylated (lane 5), did not
prevent the precipitation of His6-tagged BCK upon the
removal of arginine. The results indicate that the sequence of LBD
alone is not capable of binding to BCK.
The C-terminal Hinge Region of LBD Is Indispensable for the
Interaction of LBD with His6-tagged BCK--
The ability
of lip-DD, but not lip-LBD, to maintain the solubility of
His6-tagged BCK in the absence of arginine raises the question of whether the C-terminal SBD or the hinge sequence between LBD and the SBD is needed for binding. Therefore, solubility-based binding studies with His6-tagged BCK were carried out
further with lip-LBD constructs containing various lengths of the
C-terminal hinge region (Fig.
2A). As shown in Fig.
2B, lip-LBD2 (residues 1-99) (lane 2) and
lip-LBD3 (residues 1-95) (lane 4), both C-terminally His6-tagged, confer 100% solubility of
His6-tagged BCK in the absence of arginine.
His6-tagged BCK is absent from the supernatant with
apo-LBD2 (lane 1) or apo-LBD3 (lane 3). The
addition of lip-LBD4 (residues 1-89) (lane 6) results in
lower levels of soluble His6-tagged BCK compared with
lip-LBD2 and lip-LBD3. Identical amounts of His6-tagged BCK
were used in the solubility-based binding assays with different
constructs. Similarly, apo-LBD4 did not protect His6-tagged
BCK from precipitation upon the removal of arginine (lane
5). No His6-tagged BCK was present in the supernatant
in the presence of either apo-LBD (lane 7) or lip-LBD
(lane 8), serving as negative controls. These results
establish, for the first time, that the C-terminal hinge region of LBD
is essential for the binding of lip-LBD to BCK. The hinge regions
containing four negatively charged residues
Glu86-Glu-Asp-Xaa-Xaa-Glu that are present in lip-LBD2 and
lip-LBD3 are likely to confer efficient domain binding to BCK.
Direct Binding Measurements by Isothermal Titration
Calorimetry--
We utilized ITC as a direct method to study the
interaction of lip-LBD2 with BCK. Measurements of heat changes by ITC
require relatively large quantities of proteins especially when the
binding energy is weak. For binding studies by ITC, rat BCK was
expressed in Escherichia coli as a MBP fusion. MBP-BCK,
unlike His6-tagged BCK, is highly soluble (~50 mg/ml) in
the absence of arginine, and the presence of MBP has no effect on BCK
activity and its interaction with lipoylated E2b (11). Fig.
3 (upper panel) shows the heat
of titration with apo-LBD2 and lip-LBD2. The unchanged ITC isotherm
with apo-LBD2 unequivocally demonstrates the absence of interactions
with MBP-BCK (Fig. 3, lower panel). By comparison, lip-LBD2
shows a gradual rise in the isotherm, which is consistent with a weak
binding to MBP-BCK. Because of the weak interaction, the titration is
only ~80% saturated under the conditions used in these experiments.
From the binding isotherm, a dissociation constant
KD of 8.06 × 10 Thermodynamic Parameters for Interactions of LBD Constructs with
MBP-BCK--
The ITC method was further employed to characterize the
interactions of MBP-BCK with LBD constructs containing various lengths of the C-terminal linker region. Table I
shows that the interactions of lip-LBD2 with MBP-BCK is the most
exothermic among the four LBD constructs studied. The binding enthalpy
A prominent feature of the mitochondrial kinases comprising BCK
and PDK isoforms is the up-regulation through interaction with their
respective E2 cores of The essential determinants in the C-terminal hinge region of E2b LBD
for the binding of lip-LBD to BCK are presently uncertain. However, the
inclusion of negatively charged residues Glu-Glu-Asp-Xaa-Xaa-Glu in
lip-LBD2 and lip-LBD3 constructs results in binding efficiency similar
to lip-DD, based on dissociation constants and binding enthalpies
measured by ITC. The lip-DD construct contains the entire hinge region
connecting LBD and SBD and therefore mimics holo-E2 regarding binding
to BCK. The results with the lip-LBD constructs strongly suggest that
the negative charged residues in the C-terminal hinge region are
candidate determinants for interactions with BCK. In the BCK structure
(7), a groove formed between helices BH4 and BH3 of the B domain is
lined with positively charged residues that are suited to interact with
the negatively charged residues present in the C-terminal hinge region
of LBD, as suggested for the PDK2 structure (9). On the other hand, the
covalently attached lipoic acid is also essential for the binding of
lip-LBD constructs to BCK. Due to the aliphatic nature of the lipoic
acid moiety and the presence of hydrophobic residues in the hinge
region, there may be additional weak hydrophobic interactions between
lip-LBD constructs and BCK. The C-terminal hinge region of LBD is
located 26 Å away from the lipoylated Lys-44 in the recently
determined human LBD solution structure (20). Both structural elements
are on the same side of the BCK does not form a stable complex with lip-DD or lip-LBD constructs to
allow isolation by the conventional column chromatography or
ultracentrifugation methods. We have therefore developed the solubility-based binding assay, which facilitates screening for the
binding of domain constructs to BCK in a simple and straightforward fashion. The N-terminally His6-tagged BCK is soluble only
in the presence of high concentrations of arginine. The amphipathic
character of arginine presumably protects exposed hydrophobic
interacting surfaces of the folded protein (21). The crux of the
binding assay is based on the discovery that a molar excess of lip-DD can increase the solubility of N-terminally His6-tagged BCK
from 2-3 mg/ml in the presence of 300 mM arginine to 20 mg/ml when arginine is replaced by lip-DD. However, arginine and
lipoylated E2 domains are mutually exclusive in binding to
His6-tagged BCK as indicated by the phosphotransfer/kinase
activity assays (data not shown). The slow gradual removal of arginine
by dialysis from His6-tagged BCK in the presence of lip-DD
enables the latter to bind to BCK thereby maintaining its solubility.
The molar excess of lip-DD or lip-LBD constructs in the binding assay
ensures the optimal binding to His6-tagged BCK upon the
removal of arginine.
The ITC method offers "real time" measurements of thermodynamic
parameters for protein-ligand and protein-protein binding reactions
under defined solution conditions. ITC is ideal for studies of weak
interactions of BCK with lip-DD and lip-LBD constructs by taking
advantage of the high solubility of MBP-BCK. The dissociation constants
(KD) in the 10
-keto acid dehydrogenase
(BCKD) kinase (abbreviated as BCK) down-regulates activity of the
mammalian mitochondrial BCKD complex by reversible phosphorylation of
the decarboxylase (E1b) component of the complex. The binding of BCK to
the holotransacylase (E2b) core of the BCKD complex results in the
stimulation of BCK activity. Here we show that the lipoylated lipoic
acid-bearing domain (lip-LBD) (residues 1-84) of E2b alone does not
interact with BCK. However, lip-LBD constructs containing various
lengths of the C-terminal hinge region of LBD are able to bind to BCK as measured by a newly developed solubility-based binding assay. Isothermal titration calorimetry measurements produced a dissociation constant of 8.06 × 10
6 M and
binding enthalpy of -3.68 kcal/mol for the interaction of BCK with a
construct containing lip-LBD and the Glu-Glu-Asp-Xaa-Xaa-Glu sequence
of the C-terminal hinge region of LBD.
These thermodynamic parameters are similar to those obtained for
binding of BCK to a lipoylated di-domain construct, which harbors LBD,
the entire hinge region, and the downstream subunit-binding domain of
E2b. Our data establish that the C-terminal hinge region of LBD
containing the above negatively charged residues is essential for the
interaction between the lip-LBD construct and BCK.
![]()
INTRODUCTION
TOP
ABSTRACT
INTRODUCTION
EXPERIMENTAL PROCEDURES
RESULTS
DISCUSSION
REFERENCES
-keto acid
dehydrogenase (BCKD)1
complex catalyzes the rate-limiting step in the oxidation of branched-chain amino acids leucine, isoleucine, and valine (1). Genetic
defects in this macromolecular multienzyme complex result in the
accumulation of branched-chain amino acids leading to inheritable maple
syrup urine disease. The clinical phenotype includes early onset and
often fatal acidosis, neurological derangement, and mental retardation
among survivors (1). The mammalian BCKD complex is organized around a
cubic core of 24-meric dihydrolipoyl transacylase (E2b), to which
multiple copies of branched-chain
-keto acid decarboxylase (E1b),
dihydrolipoamide dehydrogenase (E3), BCKD kinase (abbreviated as BCK),
and BCKD phosphatase are attached through ionic interactions (2-4).
The activity of the BCKD complex is tightly regulated by a
phosphorylation/dephosphorylation cycle in response to dietary and
hormonal signals (5). Phosphorylation of Ser-292 and Ser-302 in the
subunit of E1b by BCK results in the inactivation of the BCKD complex
(6).
S-bound
forms were recently determined (7). The BCK structures feature a
nucleotide-binding (K) domain and a four-helix bundle (B) domain, which
are similar to modules found in bacterial protein-histidine kinases (8)
and the related pyruvate dehydrogenase kinase 2 (PDK2) of the
mitochondrial pyruvate dehydrogenase complex (PDC) (9). The K domain is
highly conserved between BCK and members of the GHL ATPase family (10),
with the presence of characteristic N1, G1, F, and G2 boxes and an
"ATP lid." In BCK, the direct back-to-back interaction of two
opposing K domains produces a dimeric structure in the crystal lattice.
In contrast to the K domain, the functional significance of the
extended B domain is unknown. Both ATPase (7) and
phosphotransfer/kinase (11) activities of BCK are stimulated by
lipoylated E2b. We have speculated that the E2b core binds to the B
domain of BCK to promote the interaction between the B and K domains,
resulting in the activation of BCK (7).
-keto acid dehydrogenase complexes.
![]()
EXPERIMENTAL PROCEDURES
TOP
ABSTRACT
INTRODUCTION
EXPERIMENTAL PROCEDURES
RESULTS
DISCUSSION
REFERENCES
3') the LBD, the complete C-terminal hinge region, and
the subunit-binding domain (SBD). To construct the C-terminally
His6-tagged DD expression vector, a sense primer, 5'-CCATGGGACAGGTTGTTCAGTTCAAGC-3', and an antisense primer,
5'-GCTCGAGTGGCATAATTTCAGCTTTTGGTG-3', were employed to amplify the DD
using a human E2b cDNA as template (14). The amplified DD was
digested with NcoI and XhoI, and the excised
fragment was cloned into the Pet-28a vector from Novagen (Madison, WI).
Similar strategies were used to construct vectors for the expression of
LBD (residues 1-84), LBD2 (residues 1-99), LBD3 (residues 1-95), and
LBD4 (residues 1-89).
-D-thiogalactopyranoside.
Nickel-nitrilotriacetic acid-purified DD and LBD proteins were
lipoylated in vitro with the bacterial enzyme LplA as
described previously (15).
-mercaptoethanol, and 5% glycerol. To carry
out ITC measurements, the reaction cell of a MicroCal (Northampton, MA)
VP-ITC microcalorimeter containing 1.5 ml of 100 µM
MBP-BCK was equilibrated at 20 °C. The stock of 500 µM
lip-DD or lip-LBD constructs in 10-µl increments was injected into
the cell, and heat changes due to binding were recorded. Binding
isotherms derived from the raw data were used to calculate the standard
free energy of binding (
G0) according to the
equation:
G0 =
RTlnKa, where R is the gas
constant, T is absolute temperature, and
Ka is the association constant. From binding
isotherms, the number of binding sites (n) was obtained, and
changes in enthalpy (
H0) and entropy
(
S0) were calculated according to the
equation:
G0 =
H0
T
S0. Curve-fitting and the
derivation of thermodynamic parameters were facilitated using the
MicroCal ORIGIN software package. The concentrations of MBP-BCK and E2
domain constructs were determined by A280 nm
using calculated extinction coefficients (in mg ml
1
cm
1) of 1.09 (for MBP-BCK), 1.07 (LBD2), 1.14 (LBD3),
1.16 (LBD2), and 0.74 (DD).
![]()
RESULTS
TOP
ABSTRACT
INTRODUCTION
EXPERIMENTAL PROCEDURES
RESULTS
DISCUSSION
REFERENCES

View larger version (15K):
[in a new window]
Fig. 1.
Solubility-based binding assays for the
interaction of lipoylated di-domain with BCK. Lipoylated or
unlipoylated di-domain (Lip-DD or Apo-DD) at
70 µM was incubated in 0.1 ml with N-terminally
His6-tagged BCK at 40 µM in a buffer
containing 400 mM arginine. Dialysis was carried out at
4 °C for 16 h against 50 mM Hepes buffer containing
50 mM KCl and 5 mM dithiothreitol. The dialyzed
mixtures were clarified by centrifugation, and aliquots were analyzed
by SDS-PAGE and Coomassie Blue staining. Parallel assays were carried
out with lipoylated and unlipoylated LBD (lip-DD and apo-DD,
respectively). The absence of His6-tagged BCK in the
supernatant indicates no interaction of BCK with the domain
proteins.

View larger version (15K):
[in a new window]
Fig. 2.
The requirement of the C-terminal hinge
region for LBD binding to BCK. Human LBD (residues 1-84) or LBD
constructs containing different lengths of the C-terminal hinge region
(A) were incubated with N-terminally His6-tagged
BCK in the presence of 400 mM arginine. Solubility-based
assays (B) for the binding of LBD constructs to
His6-tagged BCK were carried out as described in Fig.
1.
6 M,
a binding energy
G0 of
6.84 kcal/mol, and a
binding enthalpy
H0 of
3.68 kcal/mol were
calculated (Fig. 3, lower panel). The data represent direct
evidence for the interaction between lip-LBD2 containing the C-terminal
hinge region and MBP-BCK.

View larger version (31K):
[in a new window]
Fig. 3.
Isothermal titration calorimetry analysis of
lip-LBD2 binding to BCK. The MBP-BCK fusion (500 µM)
was titrated with 100 µM lip-LBD2 (residues 1-99, see
Fig. 2A). Upper panel, raw data obtained over a
series of 30 injections with apo-LBD2 (the upper overlay) or
lip-LBD2 (the main body). The data are plotted as heat
released (µcal/s) versus time (min). Lower
panel shows the binding isotherms of the integrated raw data. The
data were fit using ORIGIN software. For apo-LBD2, no binding; for
lip-LBD2, the ITC isotherm indicates weak binding with the dissociation
constant KD of 8.06 × 10
6
M and the binding energy
G0 of
6.84 kcal/mol.
H0 of
3.68 kcal/mol is comparable with that
of
3.70 kcal/mol measured with lip-DD. Significantly lower enthalpies
were obtained with lip-LBD3 and lip-LBD4. Smaller differences in
dissociation constants KD were observed between
lip-DD and lip-LBD2 through lip-LBD4. These thermodynamic parameters
confirm the conclusions derived from the solubility-based binding
assays that lip-LBD2 and lip-LBD3 interact with MBP-BCK to a degree
similar to lip-DD.
Comparison of thermodynamic parameters for the interactions of LBD
constructs with MBP-BCK
![]()
DISCUSSION
TOP
ABSTRACT
INTRODUCTION
EXPERIMENTAL PROCEDURES
RESULTS
DISCUSSION
REFERENCES
-keto acid dehydrogenase complexes (11, 17).
The lipoyl-containing domains of the E2 cores function both as an
anchor and a modulator for activities of the mitochondrial kinases.
Studies with the lipoylated inner L2 domain have been complicated by
the fact that the domain alone does not interact as efficiently as
holo-E2p with the PDK isoforms, except for PDK3 (13, 18). In this
communication, we show that lip-LBD alone does not bind to BCK;
however, the inclusion of various lengths of the previously neglected
C-terminal hinge region results in the interaction between the
lip-LBD constructs and BCK. This information has facilitated the
co-crystallization of BCK with lip-LBD constructs for the ongoing
structural determination by x-ray diffraction (data not shown). The L2
domain of E2p used in binding studies contained either none (13) or a
portion of the hinge region (12, 19). The omission of certain important
elements in the C-terminal hinge region of the L2 domain may explain
the weaker interaction of these lipoylated constructs with PDK isoforms
than with holo-E2.
barrel and represent two of the three
most mobile regions in LBD (the remaining one being the large L1 loop),
as indicated by the picosecond time scale of the spectral density
function J(H). These dynamic properties presumably
facilitate the interactions of both the essential lipoic acid moiety
and C-terminal hinge region with the B domain of BCK.
6 M range
derived from ITC measurements for lip-DD and lip-LBD2, lip-LBD3, and
lip-LBD4 are consistent with the weak interactions of BCK with these
E2b domain constructs. These values are four orders of magnitude higher
than those estimated for the tight binding of E1p or E3 to the DD of
the PDC from Bacillus stearothermophilius (22). On the other
hand, the binding enthalpy obtained by ITC measurements appears to be a
more accurate parameter than the dissociation constant in
differentiating binding affinity among lip-LBD constructs (Table I).
The similar strongly exothermic binding enthalpies between lip-LBD2 and
lip-DD indicate that the lip-LBD2 construct contains all the necessary
determinants present in E2b for its interaction with BCK. Finally, for
the fitting of the binding isotherm, a model based on one lip-LBD2
binding site per MBP-BCK monomer was used (Fig. 3). The best fit values generated a stoichiometry of n = 0.5, indicating that
due to the weak interactions only one of the two sites in the MBP-BCK
homodimer is occupied by lip-LBD2 under non-saturating conditions. This binding stoichiometry is consistent with that deduced from packing analysis of the BCK/lip-LBD2 crystals (data not shown).
| |
ACKNOWLEDGEMENTS |
|---|
We are indebted to Dr. Celestine Thomas for advice and assistance in ITC measurements and Dr. Mischa Machius for helpful discussions of x-ray crystallographic data on the BCK/lip-LBD2 crystals.
| |
FOOTNOTES |
|---|
* This work was supported by National Institutes of Health Grant DK-26758 and Welch Foundation Grant I-1286.The costs of publication of this article were defrayed in part by the payment of page charges. The article must therefore be hereby marked "advertisement" in accordance with 18 U.S.C. Section 1734 solely to indicate this fact.
To whom correspondence should be addressed: Dept. of Biochemistry,
University of Texas Southwestern Medical Center, 5323 Harry Hines
Blvd., Dallas, TX 75390-9038. Tel.: 214-648-2457; Fax: 214-648-8856; E-mail: David.Chuang@UTSouthwestern.edu.
Published, JBC Papers in Press, August 19, 2002, DOI 10.1074/jbc.C200430200
| |
ABBREVIATIONS |
|---|
The abbreviations used are:
BCKD, branched-chain
-keto acid dehydrogenase;
BCK, BCKD kinase;
DD, di-domain;
lip-DD, lipoylated DD;
E1b, branched-chain
-keto acid decarboxylase;
E1p, pyruvate dehydrogenase;
E2b, dihydrolipoyl transacylase;
E2p, dihydrolipoyl transacetylase;
L2, inner lipoyl domain;
LBD, lipoic
acid-bearing domain;
lip-LBD, lipoylated LBD;
PDC, pyruvate
dehydrogenase complex;
PDK, pyruvate dehydrogenase kinase;
SBD, subunit-binding domain;
MBP, maltose-binding protein;
ITC, isothermal titration calorimetry.
| |
REFERENCES |
|---|
|
|
|---|
| 1. | Chuang, D. T., and Shih, V. E. (2001) in The Metabolic and Molecular Basis of Inherited Disease (Scriver, C. R. , Beaudet, A. L. , Sly, W. S. , Valle, D. , Vogelstein, K. B. , and Childs, B., eds), 8th Ed. , pp. 1971-2006, McGraw-Hill Inc., New York |
| 2. |
Petti, F. H.,
Yeaman, S. J.,
and Reed, L. J.
(1978)
Proc. Natl. Acad. Sci. U. S. A.
75,
4881-4885 |
| 3. |
Paxton, R.,
and Harris, R. A.
(1982)
J. Biol. Chem.
257,
14433-14439 |
| 4. |
Damuni, Z.,
Merryfield, M. L.,
Humphreys, J. S.,
and Reed, L. J.
(1984)
Proc. Natl. Acad. Sci. U. S. A.
81,
4335-4338 |
| 5. | Harris, R. A., Hawes, J. W., Popov, K. M., Zhao, Y., Shimomura, Y., Sato, J., Jaskiewicz, J., and Hurley, T. D. (1997) Adv. Enzyme Regul. 37, 271-293[CrossRef][Medline] [Order article via Infotrieve] |
| 6. | Cook, K. G., Bradford, A. P., Yeaman, S. J., Aitken, A., Fearnley, I. M., and Walker, J. E. (1984) Eur. J. Biochem. 145, 587-591[Medline] [Order article via Infotrieve] |
| 7. |
Machius, M.,
Chuang, J. L.,
Wynn, R. M.,
Tomchick, D. R.,
and Chuang, D. T.
(2001)
Proc. Natl. Acad. Sci. U. S. A.
98,
11218-11223 |
| 8. | Bilwes, A. M., Alex, L. A., Crane, B. R., and Simon, M. I. (1999) Cell 96, 131-141[CrossRef][Medline] [Order article via Infotrieve] |
| 9. |
Steussy, C. N.,
Popov, K. M.,
Bowker-Kinley, M. M.,
Sloan, R. B., Jr.,
Harris, R. A.,
and Hamilton, J. A.
(2001)
J. Biol. Chem.
276,
37443-37450 |
| 10. | Stock, A. M., Robinson, V. L., and Goudreau, P. N. (2000) Annu. Rev. Biochem. 69, 183-215[CrossRef][Medline] [Order article via Infotrieve] |
| 11. |
Davie, J. R.,
Wynn, R. M.,
Meng, M.,
Huang, Y. S.,
Aalund, G.,
Chuang, D. T.,
and Lau, K. S.
(1995)
J. Biol. Chem.
270,
19861-19867 |
| 12. | Liu, S., Baker, J. C., Andrews, P. C., and Roche, T. E. (1995) Arch. Biochem. Biophys. 316, 926-940[CrossRef][Medline] [Order article via Infotrieve] |
| 13. | Tuganova, A., Boulatnikov, I., and Popov, K. M. (2002) Biochem. J 366, 129-136[CrossRef][Medline] [Order article via Infotrieve] |
| 14. | Chuang, J. L., Cox, R. P., and Chuang, D. T. (1997) J. Clin. Invest. 100, 736-744[Medline] [Order article via Infotrieve] |
| 15. | Chuang, J. L., Davie, J. R., Wynn, R. M., and Chuang, D. T. (2000) Methods Enzymol. 324, 192-200[Medline] [Order article via Infotrieve] |
| 16. | Radke, G. A., Ono, K., Ravindran, S., and Roche, T. E. (1993) Biochem. Biophys. Res. Commun. 190, 982-991[CrossRef][Medline] [Order article via Infotrieve] |
| 17. | Roche, T. E., Rahmatullah, M., Powers-Greenwood, S. L., Radke, G. A., Gopalakrishnan, S., and Chang, C. L. (1989) Ann. N. Y. Acad. Sci. 573, 66-75[CrossRef][Medline] [Order article via Infotrieve] |
| 18. |
Baker, J. C.,
Yan, X.,
Peng, T.,
Kasten, S.,
and Roche, T. E.
(2000)
J. Biol. Chem.
275,
15773-15781 |
| 19. | Mann, W. R., Dragland, C. J., Vinluan, C. C., Vedananda, T. R., Bell, P. A., and Aicher, T. D. (2000) Biochim. Biophys. Acta 1480, 283-292[CrossRef][Medline] [Order article via Infotrieve] |
| 20. |
Chang, C. F.,
Chou, H. T.,
Chuang, J. L.,
Chuang, D. T.,
and Huang, T. H.
(2002)
J. Biol. Chem.
277,
15865-15873 |
| 21. |
Qu, B. H.,
and Thomas, P. J.
(1996)
J. Biol. Chem.
271,
7261-7264 |
| 22. |
Jung, H. I.,
Bowden, S. J.,
Cooper, A.,
and Perham, R. N.
(2002)
Protein Sci.
11,
1091-1100 |
This article has been cited by other articles:
![]() |
C.-F. Chang, H.-T. Chou, Y.-J. Lin, S.-J. Lee, J. L. Chuang, D. T. Chuang, and T.-h. Huang Structure of the Subunit Binding Domain and Dynamics of the Di-domain Region from the Core of Human Branched Chain {alpha}-Ketoacid Dehydrogenase Complex J. Biol. Chem., September 22, 2006; 281(38): 28345 - 28353. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. Li, R. M. Wynn, M. Machius, J. L. Chuang, S. Karthikeyan, D. R. Tomchick, and D. T. Chuang Cross-talk between Thiamin Diphosphate Binding and Phosphorylation Loop Conformation in Human Branched-chain {alpha}-Keto Acid Decarboxylase/Dehydrogenase J. Biol. Chem., July 30, 2004; 279(31): 32968 - 32978. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. L. Chuang, R. M. Wynn, C. C. Moss, J.-l. Song, J. Li, N. Awad, H. Mandel, and D. T. Chuang Structural and Biochemical Basis for Novel Mutations in Homozygous Israeli Maple Syrup Urine Disease Patients: A PROPOSED MECHANISM FOR THE THIAMIN-RESPONSIVE PHENOTYPE J. Biol. Chem., April 23, 2004; 279(17): 17792 - 17800. [Abstract] [Full Text] [PDF] |
||||
![]() |
R. M. Wynn, M. Machius, J. L. Chuang, J. Li, D. R. Tomchick, and D. T. Chuang Roles of His291-{alpha} and His146-{beta}' in the Reductive Acylation Reaction Catalyzed by Human Branched-chain {alpha}-Ketoacid Dehydrogenase: REFINED PHOSPHORYLATION LOOP STRUCTURE IN THE ACTIVE SITE J. Biol. Chem., October 31, 2003; 278(44): 43402 - 43410. [Abstract] [Full Text] [PDF] |
||||
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| All ASBMB Journals | Molecular and Cellular Proteomics |
| Journal of Lipid Research | ASBMB Today |